Iridex (IRIX) Change in Receivables (2011 - 2026)
Iridex's (IRIX) quarterly Change in Receivables came in at -$769000.0 in Q2 2026, down 205.49% year-on-year from $729000.0 in Q2 2025, and down 259.88% quarter-over-quarter from $481000.0 in Q1 2026.
Iridex (IRIX) Change in Receivables (2011 - 2026) Analysis & Trends
Iridex's Change in Receivables history runs 16 years deep, the most recent figure standing at -$769000.0 for Q2 2026.
- On a quarterly basis, Change in Receivables fell 205.49% year-over-year to -$769000.0 in Q2 2026; TTM through Apr 2026 was $164000.0, a 5.81% increase from a year earlier, with the FY2026 full-year figure at $1.7 million, up 314.18% from the prior year.
- Change in Receivables slipped to -$769000.0 in Q2 2026 per IRIX's latest filing, from $481000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $2.5 million in Q1 2022 and bottomed at -$769000.0 in Q2 2026.
- The 5-year median for Change in Receivables is -$4000.0 (2024), against an average of $147000.0.
- Biggest YoY gain for Change in Receivables was 16133.33% in 2026; the steepest drop was 205.49% in 2026.
- Year by year, Change in Receivables stood at $63000.0 in 2022, then soared by 879.37% to $617000.0 in 2023, then plunged by 100.49% to -$3000.0 in 2024, then sank by 66.67% to -$5000.0 in 2025, then tumbled by 15280.0% to -$769000.0 in 2026.
- Per Business Quant, the three latest IRIX Change in Receivables figures stand at -$769000.0 (Q2 2026), $481000.0 (Q1 2026), and -$5000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Iridex | 15.93 Mn | 11.33 Mn | 4.74 Mn | -769,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -769,000.00 |
| Apr 4, 2026 | -769,000.00 |
| Jan 3, 2026 | 481,000.00 |
| Jan 3, 2026 | 481,000.00 |
| Sep 27, 2025 | -5,000.00 |
| Sep 27, 2025 | -5,000.00 |
| Jun 28, 2025 | 457,000.00 |
| Jun 28, 2025 | 457,000.00 |
| Mar 29, 2025 | 729,000.00 |
| Mar 29, 2025 | 729,000.00 |
| Dec 28, 2024 | -3,000.00 |
| Dec 28, 2024 | -3,000.00 |
| Sep 28, 2024 | -315,000.00 |
| Sep 28, 2024 | -315,000.00 |
| Jun 29, 2024 | -256,000.00 |
| Jun 29, 2024 | -256,000.00 |
| Mar 30, 2024 | -202,000.00 |
| Mar 30, 2024 | -202,000.00 |
| Dec 30, 2023 | 617,000.00 |
| Dec 30, 2023 | 617,000.00 |